IL-1 receptor type I — Drug Target

All drugs that target IL-1 receptor type I — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Interleukin-1 receptor antagonist · IL-1 receptor antagonist

Marketed (1)

• Kineret® (Anakinra) · Amgen · Interleukin-1 receptor antagonist · Immunology
  Anakinra is a recombinant interleukin-1 receptor antagonist that blocks IL-1 signaling to reduce inflammation.

Phase 3 pipeline (1)

• Anakinra (Kineret®) · Monash Medical Centre · IL-1 receptor antagonist · Immunology
  Anakinra blocks interleukin-1 (IL-1) receptor signaling to reduce inflammatory cytokine activity.